237 related articles for article (PubMed ID: 29578479)
1. Comprehensive Characterization of the Pyroglutamate Amyloid-β Induced Motor Neurodegenerative Phenotype of TBA2.1 Mice.
Dunkelmann T; Schemmert S; Honold D; Teichmann K; Butzküven E; Demuth HU; Shah NJ; Langen KJ; Kutzsche J; Willbold D; Willuweit A
J Alzheimers Dis; 2018; 63(1):115-130. PubMed ID: 29578479
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H
J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849
[TBL] [Abstract][Full Text] [Related]
3. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
Paouri E; Tzara O; Zenelak S; Georgopoulos S
J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal study of behavioral deficits in an AβPP transgenic mouse model of Alzheimer's disease.
Havas D; Hutter-Paier B; Ubhi K; Rockenstein E; Crailsheim K; Masliah E; Windisch M
J Alzheimers Dis; 2011; 25(2):231-43. PubMed ID: 21403389
[TBL] [Abstract][Full Text] [Related]
5. Sirtuin 2 Inhibition Improves Cognitive Performance and Acts on Amyloid-β Protein Precursor Processing in Two Alzheimer's Disease Mouse Models.
Biella G; Fusco F; Nardo E; Bernocchi O; Colombo A; Lichtenthaler SF; Forloni G; Albani D
J Alzheimers Dis; 2016 Jun; 53(3):1193-207. PubMed ID: 27372638
[TBL] [Abstract][Full Text] [Related]
6. Deceleration of the neurodegenerative phenotype in pyroglutamate-Aβ accumulating transgenic mice by oral treatment with the Aβ oligomer eliminating compound RD2.
Schemmert S; Schartmann E; Honold D; Zafiu C; Ziehm T; Langen KJ; Shah NJ; Kutzsche J; Willuweit A; Willbold D
Neurobiol Dis; 2019 Apr; 124():36-45. PubMed ID: 30391539
[TBL] [Abstract][Full Text] [Related]
7. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Metallothionein-1 Modulates the Phenotype of the Tg2576 Mouse Model of Alzheimer's Disease.
Manso Y; Comes G; López-Ramos JC; Belfiore M; Molinero A; Giralt M; Carrasco J; Adlard PA; Bush AI; Delgado-García JM; Hidalgo J
J Alzheimers Dis; 2016; 51(1):81-95. PubMed ID: 26836194
[TBL] [Abstract][Full Text] [Related]
9. Gene Dosage Dependent Aggravation of the Neurological Phenotype in the 5XFAD Mouse Model of Alzheimer's Disease.
Richard BC; Kurdakova A; Baches S; Bayer TA; Weggen S; Wirths O
J Alzheimers Dis; 2015; 45(4):1223-36. PubMed ID: 25697701
[TBL] [Abstract][Full Text] [Related]
10. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background.
Virgili J; Lebbadi M; Tremblay C; St-Amour I; Pierrisnard C; Faucher-Genest A; Emond V; Julien C; Calon F
Synapse; 2018 Apr; 72(4):. PubMed ID: 29341269
[TBL] [Abstract][Full Text] [Related]
12. Environmental enrichment lessens cognitive decline in APP23 mice without affecting brain sirtuin expression.
Polito L; Chierchia A; Tunesi M; Bouybayoune I; Kehoe PG; Albani D; Forloni G
J Alzheimers Dis; 2014; 42(3):851-64. PubMed ID: 24961946
[TBL] [Abstract][Full Text] [Related]
13. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
[TBL] [Abstract][Full Text] [Related]
14. Aβ oligomer eliminating compounds interfere successfully with pEAβ(3-42) induced motor neurodegenerative phenotype in transgenic mice.
Dunkelmann T; Teichmann K; Ziehm T; Schemmert S; Frenzel D; Tusche M; Dammers C; Jürgens D; Langen KJ; Demuth HU; Shah NJ; Kutzsche J; Willuweit A; Willbold D
Neuropeptides; 2018 Feb; 67():27-35. PubMed ID: 29273382
[TBL] [Abstract][Full Text] [Related]
15. Memory Improvement in the AβPP/PS1 Mouse Model of Familial Alzheimer’s Disease Induced by Carbamylated-Erythropoietin is Accompanied by Modulation of Synaptic Genes.
Armand-Ugón M; Aso E; Moreno J; Riera-Codina M; Sánchez A; Vegas E; Ferrer I
J Alzheimers Dis; 2015; 45(2):407-21. PubMed ID: 25790933
[TBL] [Abstract][Full Text] [Related]
16. Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer's disease.
Dumont M; Kipiani K; Yu F; Wille E; Katz M; Calingasan NY; Gouras GK; Lin MT; Beal MF
J Alzheimers Dis; 2011; 27(1):211-23. PubMed ID: 21799249
[TBL] [Abstract][Full Text] [Related]
17. Loss of interleukin receptor-associated kinase 4 signaling suppresses amyloid pathology and alters microglial phenotype in a mouse model of Alzheimer's disease.
Cameron B; Tse W; Lamb R; Li X; Lamb BT; Landreth GE
J Neurosci; 2012 Oct; 32(43):15112-23. PubMed ID: 23100432
[TBL] [Abstract][Full Text] [Related]
18. The exosome of adipose-derived stem cells reduces β-amyloid pathology and apoptosis of neuronal cells derived from the transgenic mouse model of Alzheimer's disease.
Lee M; Ban JJ; Yang S; Im W; Kim M
Brain Res; 2018 Jul; 1691():87-93. PubMed ID: 29625119
[TBL] [Abstract][Full Text] [Related]
19. Lipocalin 2 contributes to brain iron dysregulation but does not affect cognition, plaque load, and glial activation in the J20 Alzheimer mouse model.
Dekens DW; Naudé PJW; Keijser JN; Boerema AS; De Deyn PP; Eisel ULM
J Neuroinflammation; 2018 Nov; 15(1):330. PubMed ID: 30501637
[TBL] [Abstract][Full Text] [Related]
20. Early in vivo Effects of the Human Mutant Amyloid-β Protein Precursor (hAβPPSwInd) on the Mouse Olfactory Bulb.
Rusznák Z; Kim WS; Hsiao JH; Halliday GM; Paxinos G; Fu Y
J Alzheimers Dis; 2016; 49(2):443-57. PubMed ID: 26484907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
